1-Year Follow up to the 1473-IMIQ Study
A Follow-up Study to Evaluate Actinic Keratosis Recurrence Rates One Year After Completion of the 1473-IMIQ Study
1 other identifier
observational
84
1 country
1
Brief Summary
This is a 1-year follow-up study to evaluate the long-term effects in subjects who completely cleared their actinic keratosis (AK) lesions in the 1473-IMIQ study. The 1473-IMIQ study evaluated the safety and effectiveness of imiquimod 5% cream compared to a placebo cream for the treatment of AK.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2005
CompletedFirst Submitted
Initial submission to the registry
June 13, 2005
CompletedFirst Posted
Study publicly available on registry
June 14, 2005
CompletedFebruary 19, 2007
October 1, 2006
June 13, 2005
February 16, 2007
Conditions
Keywords
Interventions
Eligibility Criteria
You may qualify if:
- Subject had to participate in the 1473-IMIQ Study AND have had 100% clearance of AK lesions
You may not qualify if:
- Did not use any topical preparations in the previous treatment area within 24-hours of the scheduled visit.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Unknown Facility
Little Rock, Arkansas, 72205, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- DEFINED POPULATION
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
June 13, 2005
First Posted
June 14, 2005
Study Start
January 1, 2005
Last Updated
February 19, 2007
Record last verified: 2006-10